It is a pharma private limited company based in Baddi, Himachal Pradesh, India, established in 2018.
2018 | Baddi, Himachal Pradesh, India | ActiveCent Cure Private Limited, a active private limited company, was established on 15 March 2018 in Baddi, Himachal Pradesh, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24299HP2018PTC006913. Registered under ROC Roc Himachal Pradesh. it is unlisted. It has an authorized capital of ₹1.00 Cr and a paid-up capital of ₹9.05 M.
Employing 1 professional, Its leadership includes Hitesh Garg (Director), Amit Kumar (Additional Director), Sat Pal Garg (Director). Past directors included Hitesh Garg. It holds ₹5.16 Cr open charges and ₹4.87 Cr settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Plot No. 71 Industrial Area, Baddi, Himachal Pradesh, 173205.
U24299HP2018PTC006913
006913
15 March 2018
₹1.00 Cr
₹9.05 M
Roc Himachal Pradesh
Unlisted
Active
Explore comprehensive insights into Cent Cure Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Hitesh Garg | Director | 06 Sep 2023 | Current |
| Amit Kumar | Additional Director | 24 Dec 2024 | Current |
| Sat Pal Garg | Director | 15 Mar 2018 | Current |
| Santosh Garg | Director | 15 Mar 2018 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 29 Sep 2024 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Cent Cure Private Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 169.91% increase. The company also saw a substantial improvement in profitability, with a 301.23% increase in profit. The company's net worth Soared by an impressive increase of 82.69%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Cent Cure's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹51,633,000.00
₹48,700,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 24 Mar 2025 | Others | ₹5.08 Cr | Open |
| 20 Aug 2018 | Indian Overseas Bank | ₹0.80 M | Open |
| 06 Jul 2021 | State Bank Of India | ₹4.87 Cr | Satisfied |
Explore comprehensive loan charge details -
Cent Cure has a workforce of 1 employees as of Mar 29, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Cent Cure, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cent Cure's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Cent Cure Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was recorded as a recent event.
The activity Cent Cure Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Himachal Pradesh. was completed.
Progress on A charge with Others amounted to Rs. 5.08 Cr with Charge ID 101079922 was registered on 24 Mar 2025. was documented.
The activity A charge registered on 06 Jul 2021 via Charge ID 100468192 with State Bank Of India was fully satisfied on 01 Mar 2025. was completed.
Amit Kumar was appointed as a Additional Director was appointed as a Additional Director on 24 Dec 2024 & has been associated with this company since 1 year 14 days . was recorded as a recent event.
Hitesh Garg was appointed as a Director was appointed as a Director on 06 Sep 2023 & has been associated with this company since 2 years 4 months . was recorded as a recent event.
The CIN of Cent Cure Private Limited is U24299HP2018PTC006913.
Cent Cure Private Limited is headquartered at Plot No. 71 Industrial Area, Baddi, Himachal Pradesh, 173205.
Cent Cure Private Limited was incorporated on 15 March 2018.
The current directors of Cent Cure Private Limited are
The primary industry of Cent Cure Private Limited is Manufacturing.
Cent Cure Private Limited is unlisted.
The authorized capital of Cent Cure Private Limited is ₹1.00 Cr, and the paid-up capital is ₹9.05 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX